Literature DB >> 19027007

A novel association of mGluR1a with the PDZ scaffold protein CAL modulates receptor activity.

Jiuqin Zhang1, Shan Cheng, Ying Xiong, Yanmei Ma, Dali Luo, Andreas Jeromin, Hong Zhang, Junqi He.   

Abstract

Metabotropic glutamate receptor subtype 1a (mGluR1a) associates with the proteins mediating its receptor activity, suggesting a complex-controlled function of mGluR1a. Here, using glutathione-S-transferase pull-down, co-immunoprecipitation and immunofluorescence assays in vitro and in vivo, we have found CFTR-associated ligand (CAL) to be a novel binding partner of mGluR1a, through its PSD95/discslarge/ZO1homology domain. Deletion of mGluR1a-carboxyl terminus (CT) or mutation of Leu to Ala in the CT of mGluR1a reduces the association, indicating the essential binding region of mGluR1a for CAL. Functionally, the interaction of mGluR1a with CAL was shown to inhibit mGluR1a-mediated ERK1/2 activation, without an apparent effect, via the C-terminal-truncated receptor. These findings might provide a novel mechanism for the regulation of mGluR1a-mediated signaling through the interaction with CAL.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19027007     DOI: 10.1016/j.febslet.2008.10.054

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

Review 1.  Regulation of GPCR activity, trafficking and localization by GPCR-interacting proteins.

Authors:  Ana C Magalhaes; Henry Dunn; Stephen Sg Ferguson
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 2.  Minireview: Role of intracellular scaffolding proteins in the regulation of endocrine G protein-coupled receptor signaling.

Authors:  Cornelia Walther; Stephen S G Ferguson
Journal:  Mol Endocrinol       Date:  2015-05-05

3.  PDZ Scaffold Protein CAL Couples with Metabotropic Glutamate Receptor 5 to Protect Against Cell Apoptosis and Is a Potential Target in the Treatment of Parkinson's Disease.

Authors:  Wen Yuan Luo; Su Qian Xing; Ping Zhu; Chen Guang Zhang; Hui Min Yang; Nicholas Van Halm-Lutterodt; Li Gu; Hong Zhang
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

4.  MotifAnalyzer-PDZ: A computational program to investigate the evolution of PDZ-binding target specificity.

Authors:  Jordan Valgardson; Robin Cosbey; Paul Houser; Milo Rupp; Raiden Van Bronkhorst; Michael Lee; Filip Jagodzinski; Jeanine F Amacher
Journal:  Protein Sci       Date:  2019-11-01       Impact factor: 6.725

5.  The golgi-associated PDZ domain protein PIST/GOPC stabilizes the β1-adrenergic receptor in intracellular compartments after internalization.

Authors:  Judith Koliwer; Minjong Park; Carola Bauch; Mark von Zastrow; Hans-Jürgen Kreienkamp
Journal:  J Biol Chem       Date:  2015-01-22       Impact factor: 5.157

6.  Scaffolding protein GOPC regulates tight junction structure.

Authors:  Ruifeng Lu; Lorraine Stewart; Jean M Wilson
Journal:  Cell Tissue Res       Date:  2015-01-24       Impact factor: 5.249

7.  PDZ domains and their binding partners: structure, specificity, and modification.

Authors:  Ho-Jin Lee; Jie J Zheng
Journal:  Cell Commun Signal       Date:  2010-05-28       Impact factor: 5.712

8.  Syntaxin 6 and CAL mediate the degradation of the cystic fibrosis transmembrane conductance regulator.

Authors:  Jie Cheng; Valeriu Cebotaru; Liudmila Cebotaru; William B Guggino
Journal:  Mol Biol Cell       Date:  2010-02-03       Impact factor: 4.138

9.  PIST (GOPC) modulates the oncogenic voltage-gated potassium channel KV10.1.

Authors:  Solveig Herrmann; Milena Ninkovic; Tobias Kohl; Luis A Pardo
Journal:  Front Physiol       Date:  2013-08-14       Impact factor: 4.566

10.  Altered expression of metabotropic glutamate receptor 1 alpha after acute diffuse brain injury: Effect of the competitive antagonist 1-aminoindan-1, 5-dicarboxylic acid.

Authors:  Fei Cao; Mantao Chen; Gu Li; Ke Ye; Xin Huang; Xiujue Zheng
Journal:  Neural Regen Res       Date:  2012-01-15       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.